- Home
- EPOW vs IOBT Comparison
EPOW vs IOBT Comparison
Compare EPOW & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPOW | IOBT |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | China | Denmark |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.5M | 26.6M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EPOW | IOBT |
|---|---|---|
| Price | $0.71 | $0.22 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 126.3K | ★ 860.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.21 |
| 52 Week High | $1.86 | $2.79 |
Technical Indicators
Market Signals| Indicator | EPOW | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 28.16 |
| Support Level | $0.66 | $0.21 |
| Resistance Level | $1.02 | $0.40 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 10.75 | 0.83 |
Price Performance
Historical ComparisonAbout EPOW Sunrise New Energy Co. Ltd
E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. The company operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, it also operates a knowledge sharing platform business.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.